Increasing expressions of the EGFR and MOR in lung cancer could promote growth of tumor cells, trigger angiogenesis mediated by the vascular endothelial growth factor (VEGF), increase vascular permeability, accelerate tumor progression, and increase the risk of micrometastasis (70). The gene discussed is VEGFA; the disease is lung carcinoma.